Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cirmtuzumab Consolidation for Treatment of Patients With Detectable CLL on Venetoclax

NCT04501939 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT04501939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04501939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cirmtuzumab Consolidation for Treatment of Patients With Detectable CLL on Venetoclax
Lead sponsor
University of California, San Diego
Phase
Phase 2
Overall status
Active, not recruiting
Start date
August 6, 2020
Completion date
July 22, 2026
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia